Skip to main content
رجوع
CTNM logo

Contineum Therapeutics, Inc. Class A Common Stock

جودة البيانات: 100%
CTNM
NASDAQ Healthcare Biotechnology
KWD 13.65
▲ KWD 0.37 (2.79%)
القيمة السوقية: 509.64M
نطاق اليوم
KWD 13.03 KWD 13.80
نطاق 52 أسبوعًا
KWD 3.35 KWD 16.33
حجم التداول
137,766
متوسط 50 يوم / 200 يوم
KWD 13.74 / KWD 10.26
الإغلاق السابق
KWD 13.28

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (633 نظير)

المقياس السهم وسيط القطاع
P/E -8.5 0.2
P/B 2.0 2.9
ROE % -26.1 3.7
Net Margin % 3.9
Rev Growth 5Y % 10.0
D/E 0.0 0.2

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

النقاط الرئيسية

Debt/Equity of 0.03 — conservative balance sheet
Negative free cash flow of -55.54M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-26.13%
ROIC-18.96%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
0.03
Current Ratio27.50
Interest Coverage0.00

التقييم

P/E Ratio
-8.50
Forward P/EN/A
P/B Ratio1.95
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -59.98M
ROE -26.13% ROA -21.68%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -55.54M
ROIC -18.96% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.03 Current Ratio 27.50
Interest Coverage 0.00
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -8.50 Forward P/E N/A
P/B Ratio 1.95 P/S Ratio N/A
PEG Ratio 11.51 Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -10.90%
Market Cap 509.64M Enterprise Value 442.28M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0.0 0.0 50.00M 0.0 0.0
Net Income -59.98M -42.26M 22.72M -24.25M -29.00M
EPS (Diluted) -2.17 -2.18 0.90 -0.97 -1.15
Gross Profit -323,000.0 -258,000.0 50.00M -329,000.0 0.0
Operating Income -68.06M -50.89M -16.08M -22.72M -28.65M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 276.64M 212.85M 130.39M 50.64M 70.52M
Total Liabilities 15.65M 14.78M 198.32M 11.37M 8.93M
Shareholders' Equity 260.99M 198.07M -67.94M 39.27M 61.59M
Total Debt 8.25M 6.26M 193.19M 5.85M 4.91M
Cash & Equivalents 75.60M 21.94M 15.53M 5.57M 4.63M
Current Assets 267.92M 206.39M 127.71M 48.39M 69.78M
Current Liabilities 9.74M 9.97M 5.48M 7.55M 3.67M